Immunotec Inc.
TSX CROISSANCE : IMM
TSX VENTURE : IMM

Immunotec Inc.

July 03, 2008 23:59 ET

Immunotec announces new Chief Operating Officer

VAUDREUIL-DORION, QC, July 3 - Immunotec Inc. (TSX-V :IMM)
today announced the appointment of Daniel L. Murphy as Executive Vice
President and Chief Operating Officer, effective July 7, 2008. Mr. Murphy,
formerly Vice President Finance and Chief Financial Officer at Princess House
Inc. will report directly to James A. Northrop, President and Chief Executive
Officer of Immunotec Inc.

"I am delighted that Dan will be assuming the role of Chief Operating
Officer at Immunotec," said Jim Northrop. "Dan has proven operational skills
and brings with him a wealth of knowledge in our industry."

Dan brings to the role over twenty years of experience in both private
and public companies. Prior to joining Immunotec, he held various senior
operating positions in a variety of industries, focusing on financial
management and process improvement methodologies. In addition, Dan is the
Treasurer of the United States Direct Selling Association.

The Board of Directors of Immunotec has approved the granting of
300,000 stock options to Mr. Murphy under the company's stock option plan, at
a price of $0.56. The closing price of Immunotec Inc. shares was $0.56 on May
27, 2008.

Immunotec's head office a 37,000 square foot facility is located in
Vaudreuil-Dorion, Quebec, Canada and as well has a distribution centre located
in Swanton, Vermont, USA. Immunotec is engaged primarily in the development
and marketing of dietary supplements, food, vitamins, personal care products
and natural health products, which are manufactured on its behalf by third
parties. Immunotec's products are distributed and sold in Canada and the
United States through a network marketing system and in other countries under
distributorship agreements.

%SEDAR: 00011993EF

Contact Information